Trial intelligence / Profile preview

Hyaluronic Acid Combined With Xenograft in Immediate Implant Placement

NCT07862686Not yet recruiting

Sponsor
Cairo University
Start
Sep 2026
Primary completion
Jul 2027
Countries
1
01

Overview

Randomised trial of hyaluronic acid sodium composite gel for injection in 19p13.3 microduplication syndrome (2 arms), sponsored by Cairo University. Primary endpoint: Radiographic change in labial bone thickness at 12 months. Planned start Sep 2026; status: not yet recruiting.

02

Drugs

hyaluronic acid sodium composite gel for injection
03

Conditions

19p13.3 microduplication syndrome

Beyond the preview

Go deeper on NCT07862686.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07862686.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call